Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Experts encourage investigation of the benefits of exercise training for patients with multiple sclerosis

A team of experts encouraged ongoing investigation of the benefits of exercise training for individuals with multiple sclerosis, citing shortcomings of available studies.

19 Jul 2022

UC San Francisco neurologists focus on the hazards of abortion restrictions for women of reproductive age

UCSF Perspective Article Says New Ruling May Result in Increased Risk of Deaths, Disability.

14 Jul 2022

Few people may have symptoms of depression years before their stroke, finds study

While depression is a common problem for people who have had a stroke, some people may have symptoms of depression years before their stroke, according to a study published in the July 13, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Jul 2022

People with non-alcoholic fatty liver disease may have higher risk of dementia

People who have non-alcoholic fatty liver disease, a buildup of fat cells in the liver, may have a higher risk of dementia, according to a new study published in the July 13, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

13 Jul 2022

New center aims to accelerate research into biomarkers of neurodegenerative diseases

A new center established at Washington University School of Medicine in St. Louis aims to accelerate research into biomarkers of neurodegenerative conditions such as Huntington's and Parkinson's diseases, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS) and the so-called tauopathies, a group that includes Alzheimer's disease along with rarer diseases such as frontotemporal dementia, corticobasal syndrome and progressive supranuclear palsy.

13 Jul 2022

Researchers create a comprehensive map of how complex networks of genes function together

Using new technologies to study thousands of genes simultaneously within immune cells, researchers at Gladstone Institutes, UC San Francisco (UCSF), and Stanford School of Medicine have created the most detailed map yet of how complex networks of genes function together.

11 Jul 2022

Inclusion of VR technology in cognitive rehabilitation research and care for multiple sclerosis

In a recent article, Kessler Foundation scientists advocated for the incorporation of virtual reality (VR) technology in cognitive rehabilitation research in multiple sclerosis (MS).

30 Jun 2022

Study finds more of white matter hyperintensities in postmenopausal women

Women who have gone through menopause may have more of a brain biomarker called white matter hyperintensities than premenopausal women or men of the same age, according to a new study published in the June 29, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Jun 2022

Study finds increased risk of neurodegenerative disorders among COVID-19 positive patients

COVID-19 positive outpatients are at an increased risk of neurodegenerative disorders compared with individuals who tested negative for the virus, a new study presented today at the 8th European Academy of Neurology (EAN) Congress has shown.

25 Jun 2022

Using AI to save the lives of mothers and babies

As part of our SLAS Europe 2022 coverage, we speak to Professor Patricia Maguire from the University College Dublin about their AI_PREMie technology.

From Society for Laboratory Automation and Screening (SLAS) 24 Jun 2022

Acupuncture may help people suffering from chronic tension-type headaches

Acupuncture may reduce headaches for people who have chronic tension-type headaches, according to a study published in the June 22, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

22 Jun 2022

Cannabis consumption may relieve fatigue according to new study

Investigators recently analyzed the impacts of Cannabis flower consumption in the treatment of fatigue

20 Jun 2022

Assessing neurological symptoms present in long COVID patients

Researchers assessed the symptoms of neurological post-acute sequelae of SARS-CoV-2 infection (neuro-PASC) among patients with and without neurologic disorders.

17 Jun 2022

Cost of brand-name antiseizure medications increased by 277% from 2010 to 2018, study finds

The cost of brand-name drugs for epilepsy increased by 277% from 2010 to 2018, according to a study published in the June 15, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Jun 2022

Association of neuronal and non-neuronal GABA with neuropsychiatric illness in COVID-19 patients

A new study published in the journal Reports focused on the hijacking of the pancreatic, endothelial, and gut GABA by SARS-CoV-2 and its associated pathology along with interventions.

10 Jun 2022

Shingles is not associated with increased risk of dementia, finds study

Shingles, a viral infection caused by the reactivation of the chickenpox virus, results in a painful blistering rash along one side of the body or face from nerve inflammation. There has been scientific speculation that such inflammation may increase a person's risk of dementia.

9 Jun 2022

Social isolation may be an early indicator of increased dementia risk

Social isolation is linked to lower brain volume in areas related to cognition and a higher risk of dementia, according to research published in the June 8, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

8 Jun 2022

Profound neuroinflammation associated with long COVID

Around 36 to 53% of coronavirus disease 2019 (COVID-19) patients develop persistent chronic symptoms, often referred to as long COVID or PASC.

7 Jun 2022

Researchers repurpose a cancer drug for the treatment of neuroinflammatory diseases

The repurposing of FDA-approved drugs for alternative diseases is a faster way of bringing new treatments into the clinic.

3 Jun 2022

Cellular changes in astrocytes play a crucial role in regulating outcomes for CNS disorders

Investigators at Cedars-Sinai have comprehensively mapped molecular activity in the brain and spinal cord that is responsible for regulating the body's response to central nervous system (CNS) disorders such as Alzheimer's, Huntington's disease and spinal cord injuries.

2 Jun 2022

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Experts encourage investigation of the benefits of exercise training for patients with multiple sclerosis

UC San Francisco neurologists focus on the hazards of abortion restrictions for women of reproductive age

Few people may have symptoms of depression years before their stroke, finds study

People with non-alcoholic fatty liver disease may have higher risk of dementia

New center aims to accelerate research into biomarkers of neurodegenerative diseases

Researchers create a comprehensive map of how complex networks of genes function together

Inclusion of VR technology in cognitive rehabilitation research and care for multiple sclerosis

Study finds more of white matter hyperintensities in postmenopausal women

Study finds increased risk of neurodegenerative disorders among COVID-19 positive patients

Using AI to save the lives of mothers and babies

Acupuncture may help people suffering from chronic tension-type headaches

Cannabis consumption may relieve fatigue according to new study

Assessing neurological symptoms present in long COVID patients

Cost of brand-name antiseizure medications increased by 277% from 2010 to 2018, study finds

Association of neuronal and non-neuronal GABA with neuropsychiatric illness in COVID-19 patients

Shingles is not associated with increased risk of dementia, finds study

Social isolation may be an early indicator of increased dementia risk

Profound neuroinflammation associated with long COVID

Researchers repurpose a cancer drug for the treatment of neuroinflammatory diseases

Cellular changes in astrocytes play a crucial role in regulating outcomes for CNS disorders

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in